Browsing by Author "Arrese Jiménez, Marco"
Now showing 1 - 20 of 70
Results Per Page
Sort Options
- ItemA comparative analysis of the Spanish and Latin-American prospective drug-induced liver injury (DILI) networks(2015) Bessone, Fernando|Hernández, Nelia; Sánchez Ciceron, Adriana; Di Pace, Maria; Gualano, Gisela; Arrese Jiménez, Marco; Ruiz, Alex; Loaeza del Castillo, Aurora; Girala, Marcos A.; Carrera, Enrique
- ItemAccuracy of the BAR score in the prediction of survival after liver transplantation(2019) Martinez Castillo, Jorge Arturo; Pacheco, Sergio; Bachler, J.; Jarufe Cassis, Nicolás; Briceño, Eduardo; Guerra Castro, Juan Francisco; Benitez, Carlos; Wolff, Rodrigo; Barrera Martínez, Francisco; Arrese Jiménez, Marco
- ItemAndrographolide Ameliorates Inflammation and Fibrogenesis and Attenuates Inflammasome Activation in Experimental Non-Alcoholic Steatohepatitis(2017) Cabrera, Daniel; Wree, Alexander; Povero, Davide; Solís, Nancy; Hernández, Alejandra; Pizarro Rojas, Margarita Alicia; Moshage, Han; Torres Montes, Paula Javiera; Feldstein, Ariel E.; Cabello Verrugio, Claudio Alejandro; Brandan, Enrique; Barrera Martínez, Francisco Javier; Arab Verdugo, Juan Pablo; Arrese Jiménez, Marco
- ItemAssociation of Liver Injury From Specific Drugs, or Groups of Drugs, With Polymorphisms in HLA and Other Genes in a Genome-Wide Association Study(2017) Nicoletti, Paola; Aithal, Guruprasad P.; Bjornsson, Einar S.; Andrade, Raul J.; Arrese Jiménez, Marco
- ItemAumento aislado y sostenido de aspartato aminotransferasa por presencia de macroenzimas. Caso clínico(2016) Bustamante, Verónica; Arab Verdugo, Juan Pablo; Terc, Florencia; Poggi, Helena; Goycoolea, Manuela; Arrese Jiménez, Marco; Quiroga, Teresita; Benítez, Carlos
- ItemBeneficial effects of mineralocorticoid receptor blockade in experimental non-alcoholic steatohepatitis(2015) Pizarro, M.; Solís, Nancy; Quintero, P.; Barrera Martínez, Francisco; Cabrera, D.; Rojas-de Santiago, P.; Arab Verdugo, Juan Pablo; Padilla, O.; Roa Strauch, Juan Carlos Enrique; Moshage, H.; Wree, A.; Inzaugarat, E.; Feldstein, A.; Fardella B., Carlos; Baudrand Biggs, René; Riquelme, A.; Arrese Jiménez, Marco
- ItemBile acid supplementation improves established liver steatosis in obese mice independently of glucagon-like peptide-1 secretion(2014) Quintero, Pablo; Pizarro Rojas, Margarita Alicia; Solís, Nancy; Arab Verdugo, Juan Pablo; Padilla Pérez, Oslando; Riquelme Pérez, Arnoldo; Arrese Jiménez, Marco
- ItemBile acids and nonalcoholic fatty liver disease : molecular insights and therapeutic perspectives(2017) Arab Verdugo, Juan Pablo; Karpen, S.; Dawson P.; Arrese Jiménez, Marco; Trauner, M.
- ItemBile acids and portal hypertension(2017) Arab Verdugo, Juan Pablo; Barrera Martínez, Francisco; Arrese Jiménez, Marco
- ItemBile Acids in Cholestasis and its Treatment(2017) Arab Verdugo, Juan Pablo; Cabrera, D.; Arrese Jiménez, Marco
- ItemBlack hairy tongue during interferon therapy for hepatitis C(2015) Arab Verdugo, Juan Pablo; Vargas, J.; Morales, C.; Arrese Jiménez, Marco; Arab Verdugo, Juan Pablo; Vargas, J.; Morales, C.; Arrese Jiménez, Marco
- ItemCalcium sensing receptor effects in adipocytes and liver cells : implications for an adipose-hepatic crosstalk(2016) Villarroel, P.; Mattar, P.; D'Espessailles, A.; Arrese Jiménez, Marco; Arreguin, A.; Fuentes, C.; Reyes, M.; Cifuentes, M.
- ItemCholecystectomy and NAFLD : does gallbladder removal have metabolic consequences?(2013) Nervi, Flavio; Arrese Jiménez, Marco
- ItemCirculating microRNAs : Emerging Biomarkers of Liver Disease(2015) Arrese Jiménez, Marco; Eguchi, Akiko; Feldstein, Ariel E.
- ItemComparative effectiveness of different corticosteroid regimens in severe alcohol-associated hepatitis(Lippincott Williams and Wilkins, 2024) Islam, Alvi Husni; Díaz, Luis Antonio; Idalsoaga Ferrer, Francisco Javier; Guizzetti, Leonardo; Mortuza, Rokhsana; Dunn, Winston; Singal, Ashwani K.; Simonetto, Douglas; Ramírez Cadiz, Carolina; Zhang, Wei; Qian, Steve; Cabezas, Joaquín; Sarin, Shiv K.; Maiwall, Rakhi; Jalal, Prasun K.; Higuera De La Tijera, Fátima; Skladany, Lubomir; Bystrianska, Natalia; Rincón, Diego; Chacko, Kristina R.; Ventura Cots, Meritxell; García Tsao, Guadalupe; Abraldes, Juan G.; Kamath, Patrick S.; Arrese Jiménez, Marco; Shah, Vijay; Bataller, Ramón; Arab Verdugo, Juan Pablo
- ItemComplicaciones neurológicas en pacientes adultos sometidos a trasplante hepático ortotópico. Experiencia de un centro universitario(2008) Mellado T., Patricio; Peredo Orellana, Pilar Andrea; Valenzuela Mangini, Raúl Francisco; Arrese Jiménez, Marco; Pérez Ayuso, Rosa María; Domínguez, Pilar; Guerra Castro, Juan Francisco; Jarufe Cassis, Nicolás; Martínez Castillo, JorgeBackground: Orthotopic liver transplantation (OLT) is the treatment of choice for multiple acute and chronic end-stage liver diseases as well as for selected cases of liver malignancy and liver-site metabolic disorders. Neurological impairment is a major source of morbidity and mortality following OLT. Aim: To describe the incidence and the type of neurological complications occurring in the post-operative period of OLT in patients transplanted in our hospital. Material and methods: Between March 1994 and August 2007, 76 adult patients underwent OLT. Data on incidence, time of onset, and outcome of central nervous system (CNS) complications have been obtained from our program data base and patient charts. Results: Twenty three patients (30.3%) had CNS complications following OLT. The leading complications were immunosuppressive drug-related neurological impairment in nine patients (39.1%), peripheral nerve damage in five patients (21.7%), central pontine myelinolysis in four patients (17.4%), cerebrovascular disease in three (13%) and CNS infection in three (13%). Most CNS events (90%) occurred in the first 2 weeks after OLT. Five patients with neurological complications died (22%). Conclusions: CNS complications occurred in almost one fifth of the population studied, and they had a poor outcome, as previously reported
- ItemConcurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerations(2019) Arrese Jiménez, Marco; Barrera Martínez, Francisco; Triantafilo, Nicólas; Arab Verdugo, Juan Pablo
- ItemConversion to mycophenolate mofetil monotherapy in liver recipients: Calcineurin inhibitor levels are key(2017) Norero, Blanca; Serrano Honeyman, Carolina; Sánchez Fueyo, A.; Duarte, Ignacio; Torres Montes, Paula Javiera; Ocqueteau Tachini, Mauricio; Barrera Martínez, Francisco; Arrese Jiménez, Marco; Soza, Alejandro; Benítez, Carlos
- ItemCurrent evidence on the use of probiotics in liver diseases(2015) Chavez, N.; Gonzalez, L.; Jeong, M.; Lopez, Y.; Barbero, V.; Juarez, E.; Romero, J.; Arrese Jiménez, Marco; Mendez, N.; Uribe, M.
- ItemDiarrea poscolecistectomía : ¿un problema frecuente?(2017) Manríquez, Erik; Tejos, Rodrigo; Rojas, Alejandro; Pimentel, Eduardo; Vega, Tomás; Achurra Tirado, Pablo; Avila, Rubén; Jarufe Cassis, Nicolás; Crovari Eulufi, Fernando; Arrese Jiménez, Marco; Martínez, Jorge